IMM 2.33% 2.1¢ immutep limited

New trial by Novartis

  1. 391 Posts.
    lightbulb Created with Sketch. 8
    https://clinicaltrials.gov/ct2/show/NCT03499899



    A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer


    Column 1 Column 2
    0 Estimated Study Start Date : June 20, 2018
    1 Estimated Primary Completion Date : September 30, 2019
    2 Estimated Study Completion Date : October 12, 2020


    Glta
    Fishywoo
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
2.1¢
Change
-0.001(2.33%)
Mkt cap ! $71.16M
Open High Low Value Volume
2.2¢ 2.3¢ 2.1¢ $82.44K 3.722M

Buyers (Bids)

No. Vol. Price($)
19 10840033 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 843904 5
View Market Depth
Last update - 16.10pm 19/07/2019 (20 minute delay) ?
(live)
Last
2.2¢
  Change
-0.001 ( 0.00 %)
Open High Low Volume
2.2¢ 2.3¢ 2.2¢ 3149959
Last updated 15.55pm 19/07/2019 (live) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.